Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$177,048
in 4 filings

Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-01 French Glendon E. III President and CEO Sale −1,032 $11.49 $12K 1,205,048
2023-06-01 French Glendon E. III President and CEO Sale −1,577 $11.48 $18K 1,203,471
2023-06-01 French Glendon E. III President and CEO Sale −3,924 $11.48 $45K 1,199,547
2023-06-01 Florin Daniel P Director Grant or award +12,620 25,752
2023-06-01 Ferrari Richard Director Grant or award +12,620 42,655
2023-06-01 Burns Thomas William Director Grant or award +12,620 21,030
2023-06-01 Mead Dana G Jr. Director Grant or award +12,620 47,345
2023-03-01 Sung Derrick Chief Financial Officer Sale −458 $11.03 $5K 262,288
2023-03-01 Sung Derrick Chief Financial Officer Sale −806 $11.03 $9K 261,482
2023-03-01 Sung Derrick Chief Financial Officer Grant or award +138,000 399,482
2023-03-01 Sung Derrick Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +94,500 94,500
2023-03-01 Rose Geoffrey Beran Chief Commercial Officer Sale −437 $11.03 $5K 181,762
2023-03-01 Rose Geoffrey Beran Chief Commercial Officer Sale −769 $11.03 $8K 180,993
2023-03-01 Rose Geoffrey Beran Chief Commercial Officer Grant or award +78,900 259,893
2023-03-01 Rose Geoffrey Beran Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +54,000 54,000
2023-03-01 Lehman David Aaron General Counsel Sale −458 $11.03 $5K 43,702
2023-03-01 Lehman David Aaron General Counsel Sale −806 $11.03 $9K 42,896
2023-03-01 Lehman David Aaron General Counsel Grant or award +118,300 161,196
2023-03-01 Lehman David Aaron General Counsel Grant or award · Employee Stock Option (right to buy) +81,000 81,000
2023-03-01 French Glendon E. III President and CEO Sale −1,184 $11.03 $13K 1,034,291

Page 13 of 23 · 450 trades